Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R/R>*** > TREAT.: > USA. A. CD20xCD3 BiSpecific MAb>

---

USA. A. CD20xCD3 BiSpecific MAb>'s subsections
(*) USA Approval Date: 2024. 06.26
>Injection for SC Use
Company
Generic Name
RTM
RTM Web-Site
USA Patent Numbers

USA. A. CD20xCD3 BiSpecific MAb>'s products
This section has no products